Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00267137 · ClinicalTrials.gov registry record · NA
Study for Atrial Fibrillation Reduction (SAFARI)
A NA study of Atrial Fibrillation, Bradycardia, sponsored by Medtronic Cardiac Ablation Solutions.
- Completed
- Registry status
- NA
- Development phase
- 540
- Enrollment target
- 20
- Study locations
NCT00267137 is a NA study of Atrial Fibrillation, Bradycardia that has completed, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 540 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT00267137, a NA study of Atrial Fibrillation, Bradycardia, has completed, sponsored by Medtronic Cardiac Ablation Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 540 participants
- Enrollment target
- 20
- Study locations
Study Summary
Atrial fibrillation (AF), which is the name for rapid beats in the upper chambers of the heart, is the world's most common kind of irregular heart beat. People with AF experience symptoms such as heart palpitations (a racing or pounding feeling in the chest), shortness of breath, dizziness, fatigue or weakness. Although AF can occur in otherwise healthy people for no apparent reason, it is sometimes associated with high blood pressure, heart disease or lung problems. The purpose of the SAFARI trial is to study the effectiveness of pacing algorithms in the upper chamber of the heart for patients who have both AF and bradycardia (slow heart beat).
Conditions Studied
Interventions
- DEVICE Pacing Algorithms
Study Locations (20)
Florida
- - Clearwater
- - Daytona Beach
- - Ormond Beach
- - Tampa
California
- - Bakersfield
- - Berkeley
- - Los Angeles
Illinois
- - Chicago
- - Lombard
- - Springfield
Arkansas
- - Fayetteville
- - Fort Smith
Arizona
- - Yuma
Colorado
- - Aurora
Connecticut
- - Stamford
Georgia
- - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2002-09 |
| Est. Completion | 2006-07-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00267137
The ClinicalTrials.gov registry entry for NCT00267137 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Ablation Solutions, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation, Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Pacing Algorithms is the first listed.
NCT00267137 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT00267137 about?
NCT00267137 is a clinical study titled "Study for Atrial Fibrillation Reduction (SAFARI)". Atrial fibrillation (AF), which is the name for rapid beats in the upper chambers of the heart, is the world's most common kind of irregular heart beat. People with AF experience symptoms such as heart palpitations (a racing or pounding feeling in the chest), shortness of breath, dizziness, fatigue ...
What is the current status of trial NCT00267137?
This trial is currently completed. It is a NA study. The enrollment target is 540 participants. The study started on 2002-09. Estimated completion is 2006-07-21.
What conditions does trial NCT00267137 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Bradycardia.
What interventions are being tested in trial NCT00267137?
The interventions under investigation include: Pacing Algorithms (DEVICE).
Who is sponsoring clinical trial NCT00267137?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00267137 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.